Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of anti-clusterin oligonucleotide with Hsp90 inhibitor for the treatment of prostate cancer

Combination of anti-clusterin oligonucleotide with Hsp90 inhibitor for the treatment of prostate cancer

US Patent 9457045 · Granted Oct 4, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

B1SP fusion protein therapeutics, methods, and uses2025
Mucoadhesive polymeric drug delivery compositions and methods2024
Polymeric paste compositions for drug delivery2021
B1SP fusion protein therapeutics, methods, and uses2021
Derivatized hyperbranched polyglycerols2020
Derivatized hyperbranched polyglycerols2018
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2017
Dual targeting antisense oligonucleotides as apoptotic inhibtor therapeutic comp2017
Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase in2017
Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase in2017
Compositions and methods for treatment of prostate and other cancers2017
Derivatized hyperbranched polyglycerols2017